Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
1982
|
| gptkbp:ATCCode |
J01DD04
|
| gptkbp:brand |
gptkb:ceftriaxone
|
| gptkbp:CASNumber |
73384-59-5
|
| gptkbp:chemicalClass |
cephalosporin
|
| gptkbp:contraindication |
hypersensitivity to cephalosporins
|
| gptkbp:developedBy |
gptkb:Hoffmann-La_Roche
|
| gptkbp:eliminationHalfLife |
6-9 hours
|
| gptkbp:excretion |
urine
bile |
| gptkbp:form |
powder for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
Rocephin
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits bacterial cell wall synthesis
|
| gptkbp:pregnancyCategory |
B
|
| gptkbp:routeOfAdministration |
intramuscular
intravenous |
| gptkbp:sideEffect |
diarrhea
allergic reaction rash pain at injection site |
| gptkbp:usedFor |
gptkb:pneumonia
meningitis sepsis urinary tract infections gonorrhea bacterial infections |
| gptkbp:WHOModelListOfEssentialMedicines |
included
|
| gptkbp:bfsParent |
gptkb:Roche
gptkb:ceftriaxone gptkb:Ceftriaxone |
| gptkbp:bfsLayer |
6
|